1. Home
  2. FRAF vs CCCC Comparison

FRAF vs CCCC Comparison

Compare FRAF & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Financial Services Corporation

FRAF

Franklin Financial Services Corporation

HOLD

Current Price

$50.09

Market Cap

229.0M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.05

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRAF
CCCC
Founded
1906
2015
Country
United States
United States
Employees
306
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.0M
185.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
FRAF
CCCC
Price
$50.09
$3.05
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$12.20
AVG Volume (30 Days)
18.8K
2.2M
Earning Date
04-28-2026
05-25-2026
Dividend Yield
2.58%
N/A
EPS Growth
N/A
16.45
EPS
3.39
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.16
N/A
Revenue Growth
N/A
1.02
52 Week Low
$32.53
$1.09
52 Week High
$57.51
$3.64

Technical Indicators

Market Signals
Indicator
FRAF
CCCC
Relative Strength Index (RSI) 45.90 69.53
Support Level $44.63 $1.96
Resistance Level $52.56 $3.07
Average True Range (ATR) 1.51 0.29
MACD 0.01 0.09
Stochastic Oscillator 28.90 87.76

Price Performance

Historical Comparison
FRAF
CCCC

About FRAF Franklin Financial Services Corporation

Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: